Matt Paterson

Matt Paterson

Chief Strategy Officer

Executive Leader
About

Matt Paterson is Chief Strategy Officer at Quotient Sciences. With over 27 years of global experience in the pharmaceutical industry, Matt has held leadership roles spanning business development, marketing, and corporate strategy in CRO/CDMO businesses. 

Matt has a keen interest in early clinical research and has been instrumental in advancing Quotient Sciences’ capabilities in this area.

Group of scientists in laboratory
Translational Pharmaceutics, Clinical Pharmacology, Drug Product

Corporate Overview Info Sheet

10 March 2025 Download Now

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More